IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Knoll Capital Management, LLC

Q1 2015 Holdings

Filed 2015-05-15 | 17 holdings | $1.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Aldeyra Therapeutics Inc(ALDX)COM01438T106$1.4M135,80080.2%
Medivation, Inc.COM58501N101$283.8K2,198,91916.5%
Ampio Pharmaceuticals Inc.COM03209T109$25.5K3,388,3221.5%
Synthetic Biologics Inc.COM87164U102$7.4K3,400,8160.4%
Alcobra LtdSHSM2239P109$6.3K1,115,3150.4%
Newlink Genetics CorpCOM651511107$5.6K102,4370.3%
Advaxis Inc.COM NEW007624208$4.0K275,0000.2%
Keryx Biopharmaceuticals Inc.COM492515101$2.5K200,0000.1%
Bio Blast Pharma LtdSHSM20156101$2.0K338,1100.1%
Lion Biotechnologies IncCOM53619R102$1.2K100,0000.1%
Advaxis Inc.W EXP 07/15/201007624117$1.2K112,5000.1%
PlasmaTech BiopharmaceuticalCOM72754H109$669213,1000.0%
Galmed Pharmaceuticals Ltd(GLMD)SHSM47238106$61265,0000.0%
OHR Pharmaceutical IncCOM NEW67778H200$521205,0000.0%
Evoke Pharma IncCOM30049G104$38053,8390.0%
Zosano Pharma CorpCOM98979H103$20220,0000.0%
Aptose Biosciences IncCOM NEW03835T200$10820,0000.0%